Corey Cutler

41.3k total citations · 4 hit papers
449 papers, 18.2k citations indexed

About

Corey Cutler is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Corey Cutler has authored 449 papers receiving a total of 18.2k indexed citations (citations by other indexed papers that have themselves been cited), including 345 papers in Hematology, 127 papers in Oncology and 117 papers in Immunology. Recurrent topics in Corey Cutler's work include Hematopoietic Stem Cell Transplantation (307 papers), Acute Myeloid Leukemia Research (91 papers) and Acute Lymphoblastic Leukemia research (75 papers). Corey Cutler is often cited by papers focused on Hematopoietic Stem Cell Transplantation (307 papers), Acute Myeloid Leukemia Research (91 papers) and Acute Lymphoblastic Leukemia research (75 papers). Corey Cutler collaborates with scholars based in United States, Canada and Germany. Corey Cutler's co-authors include Joseph H. Antin, Robert J. Soiffer, Vincent T. Ho, Edwin P. Alyea, John Koreth, Haesook T. Kim, Jerome Ritz, Philippe Armand, Stephanie J. Lee and Karen K. Ballen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Corey Cutler

419 papers receiving 18.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

2011 809 citations John Koreth, Haesook T. Kim et al. profile →
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

2009 604 citations John Koreth, Joseph H. Antin et al. profile →
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

2017 473 citations R. Coleman Lindsley, Wael Saber et al. profile →
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

2012 423 citations Paul J. Martin, Corey Cutler et al. Biology of Blood and Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Corey Cutler United States	73	13.1k	6.8k	4.0k	3.2k	3.1k	449	18.2k
Vincent T. Ho United States	65	10.4k 0.8×	5.8k 0.9×	3.4k 0.9×	2.1k 0.7×	2.3k 0.7×	323	14.9k
Edwin P. Alyea United States	72	10.6k 0.8×	6.8k 1.0×	4.1k 1.0×	2.4k 0.7×	2.3k 0.7×	293	15.7k
Brenda M. Sandmaier United States	74	16.1k 1.2×	5.1k 0.8×	5.4k 1.4×	3.5k 1.1×	4.8k 1.5×	421	21.8k
Didier Blaise France	60	12.1k 0.9×	5.1k 0.8×	5.0k 1.3×	2.1k 0.7×	3.7k 1.2×	652	16.5k
Donna Przepiorka United States	59	12.0k 0.9×	5.6k 0.8×	5.5k 1.4×	3.0k 0.9×	2.6k 0.8×	197	18.2k
Todd E. DeFor United States	62	10.1k 0.8×	6.5k 1.0×	5.1k 1.3×	2.9k 0.9×	1.8k 0.6×	297	15.7k
Robert J. Soiffer United States	89	15.0k 1.1×	10.6k 1.6×	7.1k 1.8×	3.7k 1.2×	3.3k 1.1×	506	25.4k
Jeff Szer Australia	58	8.4k 0.6×	4.8k 0.7×	3.5k 0.9×	3.2k 1.0×	1.9k 0.6×	385	15.3k
Aloïs Gratwohl Switzerland	80	17.1k 1.3×	5.7k 0.8×	4.7k 1.2×	4.8k 1.5×	4.4k 1.4×	515	23.8k
Vanderson Rocha France	62	10.9k 0.8×	4.0k 0.6×	3.2k 0.8×	3.6k 1.1×	2.8k 0.9×	445	14.8k

Countries citing papers authored by Corey Cutler

Since Specialization

Citations

This map shows the geographic impact of Corey Cutler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corey Cutler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corey Cutler more than expected).

Fields of papers citing papers by Corey Cutler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corey Cutler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corey Cutler. The network helps show where Corey Cutler may publish in the future.

Co-authorship network of co-authors of Corey Cutler

This figure shows the co-authorship network connecting the top 25 collaborators of Corey Cutler. A scholar is included among the top collaborators of Corey Cutler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corey Cutler. Corey Cutler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Haesook T., Vincent T. Ho, Sarah Nikiforow, et al.. (2024). Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis. Transplantation and Cellular Therapy. 30(7). 687.e1–687.e13. 3 indexed citations

Lee, Stephanie J., Corey Cutler, Steven Z. Pavletic, & Bruce R. Blazar. (2024). Belumosudil for Chronic Graft-Versus-Host Disease after 2 or More Prior Lines of Systemic Therapy: 3-Year Follow-up of the Rockstar Study. Transplantation and Cellular Therapy. 30(2). S262–S263. 2 indexed citations

Saber, Wael, Aasthaa Bansal, Bart L. Scott, et al.. (2024). Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102. JCO Oncology Practice. 20(4). 572–580. 6 indexed citations

Gray, Tamryn F., Hermioni L. Amonoo, Lauren L. Sullivan, et al.. (2023). Family Caregiver Experiences in the Inpatient and Outpatient Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Settings: A Qualitative Study. Transplantation and Cellular Therapy. 30(6). 610.e1–610.e16. 7 indexed citations

Lee, Stephanie J., Corey Cutler, Ted Gooley, et al.. (2023). Dental evaluation and clearance prior to allogeneic hematopoietic cell transplantation. Oral Diseases. 30(4). 2635–2644. 2 indexed citations

Kelkar, Amar H., Chantal Kerssens, Hajime Uno, et al.. (2023). Feasibility of Utilizing a Virtual Health Assistant during Inpatient Reduced-Intensity Allogeneic Transplantation. Blood. 142(Supplement 1). 5104–5104.

Kelkar, Amar H., et al.. (2022). Cost-Effectiveness of CD19 Chimeric Antigen Receptor T Cell Therapy Versus Autologous Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma in First Relapse. Transplantation and Cellular Therapy. 28(3). S332–S333. 2 indexed citations

Ikegawa, Shuntaro, Haesook T. Kim, Gordon J. Freeman, et al.. (2022). Low Dose IL-2 Therapy in Patients with Chronic Gvhd Induces PD-1+treg That Are Highly Activated, Immune Suppressive, and Proapoptotic. Transplantation and Cellular Therapy. 28(3). S59–S60. 1 indexed citations

Horwitz, Mitchell E., Patrick J. Stiff, Corey Cutler, et al.. (2022). Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplant with Omidubicel Demonstrates Sustained Clinical Improvement Versus Standard Myeloablative Umbilical Cord Blood Transplantation (UCBT): Final Results of a Phase III Randomized, Multicenter Study. Transplantation and Cellular Therapy. 28(3). S73–S74. 1 indexed citations

10.

Lee, Stephanie J., et al.. (2022). Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-Versus-Host Disease Studies. Transplantation and Cellular Therapy. 28(3). S317–S318.

11.

Versluis, Jurjen, Wael Saber, Harrison Tsai, et al.. (2022). Mutation Analysis in Patients with High-Risk Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Cell Transplantation Based on Biological Donor Availability: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study 1102. Transplantation and Cellular Therapy. 28(3). S37–S38. 1 indexed citations

12.

Little, Jessica S, Roman M. Shapiro, David W. Kubiak, et al.. (2022). Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome. Transplantation and Cellular Therapy. 28(8). 508.e1–508.e8. 8 indexed citations

13.

Cutler, Corey, Stephanie J. Lee, Sally Arai, et al.. (2021). Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213). Transplantation and Cellular Therapy. 27(3). S7–S8. 3 indexed citations

14.

Maurer, Katie, Haesook T. Kim, Utkarsh Acharya, et al.. (2021). COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience. Blood Advances. 5(3). 861–871. 24 indexed citations

15.

Kim, Haesook T., Jiqiao Yang, Robert J. Soiffer, et al.. (2018). Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(11). 2344–2353. 34 indexed citations

16.

Yu, Jeffrey, Barry E. Storer, Kushi Kushekhar, et al.. (2016). Biomarker Panel for Chronic Graft-Versus-Host Disease. Journal of Clinical Oncology. 34(22). 2583–2590. 89 indexed citations

17.

Piesche, Matthias, Vincent T. Ho, Haesook Kim, et al.. (2014). Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions. Clinical Cancer Research. 21(5). 1010–1018. 10 indexed citations

18.

Koreth, John, Kristen E. Stevenson, Haesook T. Kim, et al.. (2012). Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation. Journal of Clinical Oncology. 30(26). 3202–3208. 104 indexed citations

19.

Armand, Philippe, Haesook T. Kim, Corey Cutler, et al.. (2008). Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning. Journal of Clinical Oncology. 26(35). 5767–5774. 80 indexed citations

20.

Armand, Philippe, Haesook T. Kim, Corey Cutler, et al.. (2007). Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 109(10). 4586–4588. 318 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact